Elin Nyman has established an internationally connected and interdisciplinary research programme at the interface of systems biology, artificial intelligence, metabolomics, and precision medicine. She has extensive postdoc experiences from Harvard Medical School, Oregon Health & Science University, as well as AstraZeneca. Her research has attracted competitive funding from major national funders, including the Swedish Research Council, the Swedish Heart-Lung Foundation, Forska Utan Djurförsök, and strategic programmes at Linköping University.
Her contributions have been recognised through several awards, including the IMED Science Award from AstraZeneca, the Swedish Association for Diabetology Award for Best Preclinical Thesis, and the Forum Scientium Transformer Award.
Per Wistbo Nibell
Elin Nyman is also Head of Department of Biomedical Engineering.